AtriCure (ATRC) Reports In-Line Q3 EPS

AtriCure (NASDAQ: ATRC) reported Q3 EPS of ($0.22), in-line with the analyst estimate of ($0.22). Revenue for the quarter came in at $49.9 million versus the consensus estimate of $48.13 million.

GUIDANCE:

AtriCure sees FY2018 EPS of ($0.69)-($0.74), versus the consensus of ($0.69). AtriCure sees FY2018 revenue of $198-201 million, versus the consensus of $197.91 million.

For earnings history and earnings-related data on AtriCure (ATRC) click here.

You May Also Be Interested In

• FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
• FuelCell Energy signs deal with Fit Energy for up to 380 MW of power
• Korn Ferry (KFY) Tops Q4 EPS by 2c, Beats on Revenue; Offers Q1 Guidance